Latest Xoft Inc. Stories
SAN DIEGO, Nov. 3, 2010 /PRNewswire/ -- Xoft, Inc., developer of the AxxentÂ® Electronic Brachytherapy, eBx(TM) System, announced today that it has received nearly $500,000 in grants from the Qualifying Therapeutic Discovery Project Program.
SAN DIEGO, Nov.
BARCELONA, Spain, Sept. 13 /PRNewswire/ -- Xoft, Inc., the pioneer of localized, isotope-free radiation treatment delivered in minimally-shielded clinical settings, today announced the introduction of the AxxentÂ® Electronic Brachytherapy, eBx(TM) System to physicians and distributors in Europe.
SUNNYVALE, Calif., July 15 /PRNewswire/ -- Premier Inc., an alliance of more than 2,300 U.S.
NEWPORT BEACH, Calif., June 30 /PRNewswire/ -- Xoft, the leading provider of FDA-cleared Electronic Brachytherapy Systems, announced today that Hoag Breast Care Center of Hoag Memorial Hospital Presbyterian in Newport Beach, Calif., has recently installed an AxxentÂ® Electronic Brachytherapy, eBx(TM) System to support the launch of its Intraoperative Radiation Therapy (IORT) program as part of its progressive, comprehensive approach to breast cancer treatment.
SUNNYVALE, Calif., June 22 /PRNewswire/ -- Xoft, makers of Electronic Brachytherapy systems based upon miniaturized X-ray tube technology, today announced the integration of its AxxentÂ® Electronic Brachytherapy System at the Pink Lotus Breast Center, a state of the art, fully comprehensive breast center exclusively dedicated to the prevention, screening, diagnosis and treatment of breast cancer.
SUNNYVALE, Calif., June 14 /PRNewswire/ -- The clinical benefits of isotope-free electronic radiation therapy delivered directly to cancer sites with minimal exposure to surrounding healthy tissue continues to be substantiated by multiple publications, according to Xoft, Inc., developer of the AxxentÂ® Electronic Brachytherapy, eBx(TM) System.
ATLANTA, April 29 /PRNewswire/ -- Xoft, Inc., developer of the AxxentÂ® Electronic Brachytherapy, eBx(TM) System, which delivers non-radioactive, electronic radiation therapy directly to cancer sites with minimal radiation exposure to surrounding healthy tissue, announced 10 new installations of the Axxent eBx System for the treatment of skin cancer.
LAS VEGAS, April 28 /PRNewswire/ -- Utilization of the FDA cleared AxxentÂ® Electronic Brachytherapy, eBx(TM), System to deliver intraoperative radiation therapy (IORT) is growing as clinical experience demonstrates the isotope-free cancer treatment platform is a patient and physician friendly alternative.